跳至主要内容
临床试验/NCT00604266
NCT00604266撤回不适用

Coregistration of 18F-FDG-PET and MRI in the Staging of Potentially Resectable Hilar Cholangiocarcinoma: a Pilot Study.

University of Toronto1 个研究点 分布在 1 个国家开始时间: 2007年8月最近更新:
适应症

试验速览

阶段
不适用
状态
撤回
试验地点
1

研究概览

简要总结

To evaluate the feasibility and performance of coregistered 18F-FDG-PET/MRI in the staging of potentially respectable hilar cholangiocarcinoma.

研究设计

研究类型
Observational
观察模型
Case Only
时间视角
Prospective

入排标准

年龄范围
18 Years 至 99 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Hilar cholangiocarcinoma assessed by conventional imaging modalities (triphasic CT scan of the liver) and thought to be potentially resectable.

排除标准

  • Biliary drain inserted.
  • Contraindication for MRI.
  • Pregnant or breast-feeding.
  • Uncontrolled diabetes (over 9.7 mmol/L).

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Ur Metser

Division Head, Molecular Imaging, Joint Department of Medical Imaging

University of Toronto

研究点 (1)

Loading locations...

相似试验